Cancer
Updated: eribulin versus taxanes with trastuzumab-pertuzumab for first-line advanced breast cancer
A new analysis of the Japanese JBCRG-M06/EMERALD trial is sharpening the debate over how best to deliver first-line therapy for...
Immune-toxicity model and efficacy biomarkers enable precise NSCLC immunotherapy stratification
A new analysis of the phase 3 ORIENT-11 trial suggests that the future of lung-cancer immunotherapy may depend not only...
New Late-Breaking Abstracts for the 2026 MASCC/ISOO Annual Meeting
A major collection of late-breaking research from the 2026 MASCC/ISOO Annual Meeting has been published in Supportive Care in Cancer,...
Symptom Appraisal and Help-Seeking Behaviors Delay Cancer Diagnosis in Young Adults
Cancer is often described as an older person’s disease, but a qualitative study of young adults in the United States...
Cancer Survivors’ Follow-Up Oncology Visits Shifted to Primary Care, Study Finds
Cancer survivors who leave specialist oncology clinics for follow-up in primary care are not disappearing from the cancer system, according...
THINKERS: AI Combines Neural and Expert Reasoning for Lung Cancer Brain Metastases
A new artificial intelligence model is opening a potential path toward more personalized treatment for patients whose lung cancer has...
Stereotactic radiation shows favorable bowel-related quality of life in localized prostate cancer
Philadelphia—A large randomized clinical trial has found that stereotactic body radiation therapy (SBRT), an increasingly used form of highly focused...
USP30-AS1 micropeptide drives tumor growth by suppressing macrophage cGAS–STING interferon signaling
Immune checkpoint inhibitors have transformed cancer treatment by releasing molecular brakes that otherwise restrain T cells, yet their benefits remain...
Debate Over Cost-Effectiveness of DPYD Testing Before Capecitabine in Metastatic Breast Cancer
A routine genetic test performed before capecitabine treatment could help prevent some of the most serious and avoidable toxic reactions...
CXCR2 antibodies target tumors and neutrophils, enhancing immunotherapy in ARID1A-deficient pancreatic cancer
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!